Amwise is a series b startup based in China. 1 investor tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
Amwise is a Chinese biotechnology company focused on the research and development of innovative technologies for early cancer screening and diagnosis, primarily using DNA methylation detection.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky